Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Alpha Cognition Inc C.ACOG

Alternate Symbol(s):  ACOGF

Healthcare Biotechnology
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

CSE:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG.v CEO Michael McFadden talks Alpha-1062 TBI study
View:
Post by culturedpiggy01 on Dec 21, 2021 4:07pm

$ACOG.v CEO Michael McFadden talks Alpha-1062 TBI study

great video of $ACOG.v CEO Michael McFadden talking about their Alpha-1062 Traumatic Brain Injury Study https://www.youtube.com/watch?v=-QQSJNvmUuc
the inhibitor could be used to treat Alzheimer’s, I highly recommend you check it. Really intriguing stuff 
 
td, $ACOG trading at $1.06 with market cap at $65.19 M
Comment by ferret_ca on Dec 22, 2021 12:25pm
well it doesn't look like the interview or presentation did anything to interest prspective buyers or trigger existing shareholders to add shares, still a bit of tax loss selling, the pushing out next results a bit has definitely hurt. I did add a few over the last couple of days but will keep it to a smaller weighting  due to risk and size and my age, lol. cheers, happy holidays and gl& ...more  
Alpha Cognition Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities